Home
About Us
Our Science
Join Us
Investors
Contact Us
A knight at the OPERA? Kraken the RNA code, Korro on (r)ADAR with $91.5M Series A
Post navigation
Previous Post
Previous
Biotech plans first drug trial, C-suite hiring push after $91.5M round
Next Post
Next
Korro Bio’s $91.5M Series A brings in new investors, launches hunt for CEO
